Increased Intracranial Pressure on a Patient with Neuromyelitis Optica Spectrum Disorder

Overview

Journal Caspian J Intern Med

Specialty General Medicine

Date 2021 Nov 11

PMID 34760100

Authors

Seyed Mohammad Forouzannia

Pourya Yarahmadi

Mohammad Alirezaei

Nasim Rezaeimanesh

Abdorreza Naser Moghadasi

Affiliations

Soon will be listed here.

Abstract

Background: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune astrocytopathic disease affecting central nervous system (CNS). CSF pressure in these patients is usually normal.

Case Presentation: A 30-year-old woman was admitted with complaints of headache and lower limbs paresis. Lumbar puncture (LP) and magnetic resonance imaging were performed for the patient. Opening pressure was 42 cm H2O in the first LP. According to the clinical evidences, imaging, and the patient's positive aquaporin-4 antibody, the diagnosis of NMOSD was established.

Conclusion: High intracranial pressure headache; however rare, may be the first sign of the onset of the acute exacerbation phase of NMOSD.

References

Sahraian M, Naser Moghadasi A, Azimi A, Asgari N, Akhoundi F, Abolfazli R . Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations. Mult Scler Relat Disord. 2017; 18:144-151. DOI: 10.1016/j.msard.2017.09.015. View

Naser Moghadasi A . Letter to the Editor: Lack of Attention to Epidemiological Study of Neuromyelitis Optica Spectrum Disorder Compared with that of Multiple Sclerosis in Iran. Int J MS Care. 2020; 21(6):281. PMC: 6928582. DOI: 10.7224/1537-2073.2019-043. View

Seyed Ahadi M, Naser Moghadasi A, Asgari N, Sahraian M . Efficacy and safety of rituximab in patients with refractory neuromyelitis optica spectrum disorders: A prospective observation in Iranian cases. Caspian J Intern Med. 2020; 11(2):155-162. PMC: 7265520. DOI: 10.22088/cjim.11.2.155. View

Dhungana S, Waters P, Ismail A, Woodroofe N, Vincent A, Sharrack B . Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension. J Neurol. 2010; 257(7):1211-2. DOI: 10.1007/s00415-010-5499-2. View

Wingerchuk D, Banwell B, Bennett J, Cabre P, Carroll W, Chitnis T . International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015; 85(2):177-89. PMC: 4515040. DOI: 10.1212/WNL.0000000000001729. View

Viswanathan S, Wong L . A curious case of neuromyelitis optica spectrum disorder co-existing with idiopathic intracranial hypertension. J Clin Neurosci. 2017; 41:104-106. DOI: 10.1016/j.jocn.2017.03.026. View

Masters-Israilov A, Robbins M . Headache in Neuromyelitis Optica. Curr Pain Headache Rep. 2017; 21(4):20. DOI: 10.1007/s11916-017-0620-1. View

Eskandarieh S, Nedjat S, Azimi A, Naser Moghadasi A, Sahraian M . Neuromyelitis optica spectrum disorders in Iran. Mult Scler Relat Disord. 2017; 18:209-212. DOI: 10.1016/j.msard.2017.10.007. View

Friedman D . Aquaporin-4 antibodies and idiopathic intracranial hypertension: the jury is in and the channels are out. Cephalalgia. 2012; 32(3):183-4. DOI: 10.1177/0333102411436124. View

10.

Wang X, Jiao W, Lin M, Lu C, Liu C, Wang Y . Resolution of inflammation in neuromyelitis optica spectrum disorders. Mult Scler Relat Disord. 2018; 27:34-41. DOI: 10.1016/j.msard.2018.09.040. View

11.

Abboud H, Petrak A, Mealy M, Sasidharan S, Siddique L, Levy M . Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange. Mult Scler. 2015; 22(2):185-92. PMC: 4795457. DOI: 10.1177/1352458515581438. View

12.

KEEFE R . Neuromyelitis optica with increased intracranial pressure. AMA Arch Ophthalmol. 1957; 57(1):110-1. DOI: 10.1001/archopht.1957.00930050118020. View

13.

Weinshenker B, Wingerchuk D . Neuromyelitis Spectrum Disorders. Mayo Clin Proc. 2017; 92(4):663-679. DOI: 10.1016/j.mayocp.2016.12.014. View

14.

Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R . Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci. 2011; 306(1-2):82-90. DOI: 10.1016/j.jns.2011.03.038. View